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Antibody-coating of bacteria in the urine in relation to various
immunologic indexes. Little is known about the immunologic
aspects of antibody coating, though the test for determining
antibody-coated bacteria in urine has been examined for its
diagnostic uses by many authors alter its inauguration in 1974.
In adults with chronic pyelonephritis with and without antibody-
coated bacteria in the urine, we tested whether bacterial coating
is correlated with the homologous 0-antibody titre in the urine.
We also determined Ig levels in urine and serum, as well as
homologous 0-antibody titres in serum. By means of indirect
immunofluorescence technique, we were able to show homolo-
gous 0-antibodies in the urine of all patients with and without
antibody-coated bacteria. IgG and IgA levels in urine were
mostly raised, as were often the 0-antibody titres in the serum.
There were no significant differences in the immunologic pa-
rameters within the patient groups with or without antibody-
coating. The presence of homologous 0-antibodies in urine does
not therefore necessarily lead to coating of the bacteria.
Recouvrement des bactéries par des anticorps en relation avec
divers index immunologiques. Les connaissances concernant
l'aspect immunologique du recouvrement par des anticorps sont
peu nombreuses bien que le test de detection dans l'urine de bac-
téries recouvertes d'anticorps ait été évalud pour son utilitC
diagnostique par de nombreux auteurs depuis sa description en
1974. Chez des adultes atteints de pyélonéphrite chronique avec
et sans presence dans l'urine de bactéries recouvertes
d'anticorps nous avons recherché une correlation entre ce re-
couvrement et le titre d'anticorps homologue 0 dans l'urine.
Nous avons aussi détermind les concentrations d'Ig dans l'urine
et le serum, de méme que le titre de l'anticorps homologue 0
dans le serum. Au moyen de Ia technique d'immunofluorescence
indirecte nous avons pu mettre en evidence des anticorps homo-
logues 0 dans les urines de tous les malades, qu'elles con-
tiennent ou non des bactéries recouvertes d'anticorps. Les con-
centrations d'IgG et d'IgA dans l'urine étaient le plus souvent
élevées de mCme que les titres d'anticorps 0 dans Ic serum. Ii
n'a pas été observe de difference significative dans les index im-
munologiques dans les groupes de malades avec ou sans re-
couvrement des bactéries par des anticorps. La presence
d'anticorps homologues 0 dans l'urine n'implique pas ndces-
sairement le recouvrement des bactéries.
authors for its diagnostic relevance [3—il]. Not all
authors have confirmed these initial findings, name-
ly, that results are nearly always positive in pyelo-
nephritis but negative in cystitis. The differing re-
sults obtained by various workers raises the ques-
tion of the needed prerequisites for the antibody-
coating of bacteria to take place.
We asked how well the presence of homologous
0-antibodies in the urine of patients with chronic
pyelonephritis might correlate with the antibody-
coating of the organisms. At the same time, we de-
termined quantitatively the homologous 0-anti-
bodies in serum, as well as IgG, IgA, and 1gM levels
in urine and serum, so as to gain insight into the
behavior of these immunologic parameters in pyelo-
nephritis patients with and without antibody-coated
bacteria.
Methods
Patients. Nine patients with and six patients
without antibody-coated bacteria in urine, selected
arbitrarily from 206 adults with chronic pyelone-
phritis, were investigated. We examined these 15
adults and took midstream urine specimens (MSU)
for bacteriologic examination, as well as serum, and
urine collected over a 24-hour period, so as to deter-
mine the 0-antibodies and levels of IgG, IgA, and
1gM.
The diagnosis of chronic pyelonephritis was
based on a past history of symptomatic urinary tract
infections, documentation of significant bacteriuria
Since the method of detecting antibody-coated
bacteria in the urine was first introduced by Thom-
as, Shelokov, and Forland [1] and Jones, Smith, and
Sanford [2], it has been examined by many other
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(greater than 10° bacteria/mi) on at least three occa-
sions, serum creatinine concentrations greater than
1.2 mg/dl, and characteristic changes on Addis
counts of the urine sediment (leukocytes more than
5 Mio per 24 hours, erythrocytes more than 1.5 Mio
per 24 hours). In addition, i.v. pyeiography per-
formed in each patient demonstrated one or more of
the following changes: scar formation, displace-
ments of calyx-parenchyma relation, deformation of
the renal pelvis (distortion with clubbing), and club-
bing of calyces with or without shrinkage. During
the time of observation, only 4 of our 15 patients
were treated with chemotherapeutics (Tables 1 and 3).
Bacteriologic urine diagnosis. The number of or-
ganisms was determined from the MSU and the dif-
ferent types biochemically differentiated. For E.
coli, we also undertook serotypic identification with
44 anti-E. coli 0-sera [12].
Determination of antibody-coated bacteria in
urine. We centrifuged 2 ml of MSU at X3,500 rpm
and incubated this twice with PBS-washed sedi-
ment (pH, 7.3), together with FITC-labeled anti-
human globulin, for 45 mm at 37° C. We then
washed again the sediment-conjugate mixture with
PBS and prepared it for a slide. This we assessed
under a fluorescence microscope at X 1,000 magnifi-
cation. A positive urine sediment was marked by
the presence of numerous bacteria with marginal
fluorescence in most of the visual fields. We have
described the details of the technique and its evalu-
ation in earlier papers [4, 16].
Preparation of urine samples. The 24-hour urine
was collected by the patients in glass flasks without
adding any antiseptic. A 200-ml aliquot was taken
from the total volume and dialyzed for 2 to 3 days
against twice-distilled water. The urine was then
lyophilized and the lyophilisate dissolved, so that
we were left with urine in a X 100 concentration.
This was stored at —18° C until further processing.
Determination of IgG, IgA, and 1gM in urine and
serum. Quantitative determination of immunoglob-
ulins was carried out with the Mancini technique as
described by Rogos and Wagner [17], slightly modi-
fied. Reference sera from Behringwerke (Federal
Republic of Germany) were used as standard, and
antisera from Sevac (Prague, CSSR) were used for
the production of the immune diffusion plates. Pa-
tients' sera were diluted as follows: IgG determina-
tion, 1:20; IgA, 1:5; and 1gM, 1:3. The urine was
used in a 1:100 concentration. Details of the Mancini
technique have been described by Budde [16].
Quantitative antibody determination in urine and
serum. For this, we used the 0-antigen of the pa-
tient strain, taking a suspension of the organism
previously treated in a steam sterilizer and sub-
sequently washed; this suspension was fixed at a
concentration of about 1 07 organism s/ml [16]. For
the indirect immunofluorescence technique, we
fixed the antigen onto slides and incubated it with
the diluted serum or urine at 37° C for 45 mm in the
humid chamber. We then fixed FITC-labeled anti-
human globulin onto the slides, and after renewed
incubation removed this by rinsing. The titres,
which were shown by the stage of dilution still ex-
hibiting a definite fluorescent outline, were deter-
mined under the fluorescence microscope. We have
described previously the details of the immuno-
fluorescent technique [14, 16].
Results
Out of a large number of patients with chronic
pyelonephritis and significant bacteriuria, we tested
15 patients for the presence of antibody-coated bac-
teria in urine. Antibody-coating was found in 9 pa-
tients, and none in 6. The two groups tested do not
reflect the real ratio of antibody-coating in our pa-
tients. We also determined the homologous 0-anti-
bodies and IgG, A, and M levels in their urine and
serum. Bacteriologic-immunologic results in the 9
patients with evidence of antibody-coating are
shown in Tables 1 and 2.
All 9 patients had 0-antibodies against the urine
strain in the 24-hour urine samples. The 0-antibody
titres differed considerably; the highest was 1:256 in
patient 8. Serum 0-titres concurrently determined
lay between 1:320 and 1:2560 (patients 5 and 9, and
4 and 6, respectively). Table 1 shows no evidence of
Table 1. Bacteriologic and immunologic results in the urine and
serum of patients with antibody-coated bacteria
Patient Urinary strain
Reciprocal immuno-
fluorescence titre
Urinea Serum
1 E.coli 024 1 1280
2° E.colinte 4 1280
3 E. co/i nt 4 640
4 E.coliO6 8 2560
5 E.colint 1 320
6 Klebsiellapneu,noniae 128 2560
7d Proteus inconstans 1 640
8 E. co/i 07 256 640
9 E.colint 16 320
a Urine concentrated 100-fold
Ampicillin therapy (4 g/day) started two days before exami-
nation
Not able to be typed with the antisera used
d Gentamicin therapy (120 mg/day) started 6 days before exam-
ination
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Table 2. Immunoglobulins in the urine and serum of patients with
antibody-coated bacteria
Immunoglobulin
in urine
mg per 24 hr
Immunoglobulin
in serum
mg/dl
Patient Sex IgG IgA IgMa IgG IgA 1gM
1
2
3
4
5
6
7
8
9
F
F
F
F
M
F
F
F
F
21.7 5.9 ND
11.0 3.9 0.5
20.2 7.0 1.6
4.9 1.6 ND
8.7 4.0 ND
19.6 3.2 ND
40.5 9.0 ND
7.2 1.3 ND
27.0 10.5 ND
810
1680
1350
1250
1050
1385
1050
960
1250
140
330
120
205
390
175
390
105
160
65
123
165
168
105
234
220
195
187
a ND is not detectable.
a connection between heights of urine and serum
titres. Thus, patient 1 had homologous antibodies
only in the concentrated urine, but the serum titre
was 1:1280. Patient 8's urine titre was 1:256 and
serum 1:640. Table 2 shows IgG values in serum
and urine for these patients. Urine IgG levels varied
between 4.9 and 40.5 mg per 24 hours in the 9 pa-
tients. Urine 1gM was found only in 2 patients.
Urine IgA levels varied from 1.3 to 10.5 mg per 24
hours (Table 2). IgG serum levels were between 810
and 1680 mgldl, serum IgA between 105 and 390 mg/
dl, and 1gM between 65 and 234 mgldl. All were fe-
male except for patient 5.
Bacteriologic-immunologic results obtained from
the 6 patients without evidence of antibody coating
of bacteria are summarized in Tables 3 and 4.
These 6 pyelonephritis patients had homologous
0-antibodies in their urine. Antibody titres fluc-
tuated between 1:4 and 1:32. Serum titres (also de-
termined by the indirect immunofluorescence tech-
nique) varied from 1:20 to 1:2560 (patients 4 and 6,
and also patient 1 in Table 3). Ig levels also fluc-
tuated greatly from one patient to another (Table 4).
Urine IgG levels varied between 2.4 and 107.3 mg
per 24 hours, and IgA from 0.2 to 20.9. 1gM was
found only in the urine of patient 2. As with the pa-
tients with antibody-coated bacteria, we were un-
able to find a connection between serum and urine
Ig levels. Also we could not find any relationship
between the height of the homologous 0-titres in
urine and serum and the urine 1g. Thus, patients 3,
4, and 5 (Tables 3 and 4) had a urine titre of 1:32, but
the urine Ig levels lay under 8 for IgG and under 3
for IgA per 24 hours.
Only 4 patients had received treatment with anti-
biotics during the observation time. Details of the
chemotherapy are given in Tables 1 and 3.
Table 3. Bacteriologic and immunologic results in the urine and
serum of patients without antibody-coating of bacteria
Patient Urinary strain
Reciprocal immuno-
fluorescence titre
Urinea Serum
1b Proteus mirabilis 8 2560
2C Proteus mirabilis 4 1280
3 E. coli nt 32 320
4 E. coli nt 32 20
5 E. coli nt 32 640
6 E.coljnt 4 20
a Urine concentrated 100-fold
b Chloramphenicol therapy (1.4 g/day) started 12 days before
examination
Gentamicin therapy (120 mg/day) started 7 days before exam-
ination
Table 4. Immunoglobulins in the urine and serum of patients
without antibody-coating of bacteria
Patient Sex
Immunoglobulin
in urine
mg per 24 hr
1mm
i
IgG
unoglo
n serum
mg/dl
IgA
bulin
1gMIgG IgA IgMa
1
2
3
4
5
6
F
M
F
F
F
F
6.2 3.4 ND
107.3 20.9 15.5
7.4 2.0 ND
2.6 0.3 ND
2.4 0.2 ND
3.0 0.6 ND
750
2040
905
1980
4350
1260
98
250
120
90
455
255
135
360
216
168
384
234
ND is not detectable.
Discussion
Since the test for determining antibody-coated bac-
teria in urine sediment of patients with urinary tract
infection [1, 2] was introduced, its diagnostic rele-
vance has been examined by several workers.
Though special immunologic aspects connected
with it have also been examined, the prerequisites
responsible for the sequence of the antigen-anti-
body reaction, and leading to bacterial coating, are
largely unknown. Also, no investigations in man
correlating quantitative behavior of urine 0-anti-
bodies with the coating of bacteria have been pub-
lished.
Immediately after inaugurating the test, Thomas
et al [18, 19] answered questions relating to bac-
teriologic-immunologic matters connected with it,
evaluating immunologic data of patients with pyelo-
nephritis and cystitis in more detail. In three women
with pyelonephritis, negative when tested for anti-
body coating, they also found low serum antibody
titres, whereas patients with a positive result mainly
showed raised serum titres. These were also normal
in all cystitis patients [19]. In pyelonephritis pa-
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tients with antibody-coated organisms, coating was
mainly due to IgG, and more rarely by IgA anti-
bodies. They noted in a later paper that there was
no correlation between the existence of antibody-
coated bacteria and raised Ig levels in the urine.
They interpreted these results as pointing to the
specificity of the test [18]. We must ask ourselves
what caused such findings as our group found a pos-
itive antibody-coating with only 73.1% of adult py-
elonephritis patients [4] and often none at all in chil-
dren [7, 10, 20, 21].
Though we know that the urine of patients with
urinary tract infections may contain antibodies
against the homologous causative organism [14, 22,
23], to our knowledge no quantitative antibody de-
terminations have been made in human urine in
connection with this test. It was to be expected that
0-antibodies specific to a particular organism in the
urine were related to the presence or absence of
antibody-coating of bacteria. The findings of Smith,
Jones, and Kaijser in animal experiments [24] re-
flect with great sensitivity the local immune re-
sponse to the organisms's 0-antigen, and show that
all animals infected had a positive test for antibody-
coated bacteria after day 15 of infection. But only
86% and 93% of the animals had urinary antibodies
of the IgG and 1gM classes, respectively. These re-
sults reflect an acute form of renal infection in con-
trast to our patients with chronic pyelonephritis.
In all 9 patients with pyelonephritis and antibody-
coated bacteria, we found evidence of homologous
antibodies in the 24-hour urine samples (Table 1).
The 0-titres varied considerably from normal levels
up to 1:256. In healthy subjects, we found urinary
0-antibodies against 11 frequently occurring E. coli
0-antigens with an upper limit of 1:2 [13]. Urine Ig
levels were mostly raised (Table 2) [16]; serum Ig
levels, in contrast, were often within the normal
range. Here we must bear in mind the great individ-
ual fluctuation in urine and serum Ig ranges, which
we have discussed elsewhere [16].
Additionally, all those pyelonephritis patients
without evidence of antibody-coating possessed 0-
antibodies against the urine strain in collected urine
obtained at the same time. Urine titres here, deter-
mined by the indirect immunofluorescence tech-
nique, were mostly within the pathologic range [14].
The other immunologic parameters did not differ
significantly from those in patients with antibody-
coating. Only urine IgG and IgA values were lower,
except for patients 2 and 3 (Table 4). We would not
attach too much importance to this, as the literature
does not confirm any correlation between urine Ig
levels and antibody-coating [18, 19, 25]. Still, 4 of
our 6 patients without antibody-coating had urine
IgG and IgA levels above the mean value found in
healthy subjects [16]. Both groups studied (9 and 6
patients, respectively) do not reflect the results esti-
mated in all patients with pyelonephritis when the
test for detecting antibody-coated bacteria in urine
is used. We found a positive test in 64.3% and
73.1% [16, 4], respectively. It cannot be excluded
that urine samples without antibody-coating are to
be found in additional investigations without homol-
ogous 0-antibodies.
The above results argue against the existence of a
correlation between 0-antibody titres in the urine
specific to a particular organism, and an antibody-
coating of the organism. Our results indicate that
the presence of homologous 0-antibodies in the
urine need not necessarily cause a coating, and this
must be due to a factor present in the urine or on the
bacteriologic surface. It is possible that such an in-
fluence is brought about by chemotherapeutics, or
the organism's K antigen, or both.
Because in both groups only 2 patients were
treated with antibiotics during the observation time
(Tables 1 and 3), no exact conclusion can be drawn
concerning this problem.
The results of Smith et al [24] also underscore the
many facets of the problem. They found in animal
experiments that urine 0-antibodies, but not K-
antibodies, were responsible for the coating. In con-
trast to these authors, who found bacterial coating
in urine containing antibodies during its in vitro in-
cubation, Kohnle et al [25] were unable to achieve
antibody-coating of subculture organisms in urine
that had been rendered sterile. Thomas et al [26]
demonstrated that free urinary antibodies in vitro in
patients with renal infections were not only reactive
with the patient's own strain but also with heterolo-
gous bacteria.
These results stress the need for increased atten-
tion to special immunologic aspects of the test for
determining antibody-coated bacteria in the urine.
Reprint request to Dr. E. Budde, institute of Medical Micro-
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